Dr. Reddy's Laboratories Files 6-K Report
Ticker: RDY · Form: 6-K · Filed: Apr 16, 2025 · CIK: 1135951
| Field | Detail |
|---|---|
| Company | Dr Reddys Laboratories Ltd (RDY) |
| Form Type | 6-K |
| Filed Date | Apr 16, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
TL;DR
DRL filed a 6-K, confirming its foreign private issuer status and 20-F filing for annual reports.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on April 16, 2025, to report its status as a foreign private issuer. The company, based in Hyderabad, India, is subject to reporting requirements under the Securities Exchange Act of 1934 and will file its annual reports under Form 20-F.
Why It Matters
This filing confirms Dr. Reddy's Laboratories' ongoing compliance with SEC regulations for foreign private issuers, providing transparency for investors.
Risk Assessment
Risk Level: low — This is a routine administrative filing confirming the company's reporting status.
Key Players & Entities
- Dr. Reddy's Laboratories Ltd. (company) — Registrant
- Securities and Exchange Commission (company) — Regulatory body
- April 16, 2025 (date) — Filing date
- Hyderabad, India (location) — Company headquarters
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, indicating the company's reporting obligations.
What is Dr. Reddy's Laboratories' filing status for annual reports?
Dr. Reddy's Laboratories indicates it files or will file annual reports under cover of Form 20-F.
When was this Form 6-K filed?
This Form 6-K was filed on April 16, 2025.
Where is Dr. Reddy's Laboratories principal executive office located?
The principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
What is the Commission File Number for Dr. Reddy's Laboratories?
The Commission File Number is 1-15182.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 16, 2025 regarding DR REDDYS LABORATORIES LTD (RDY).